🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could result in individuals administering substances of unknown origin.

Several experts said the popularity for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking fines, legal action or imprisonment.

Service Reaction and Content Elimination

Based on TikTok, the platform has taken down problematic material and banned associated keywords and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also found communities with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, filled with images of weight loss, positive reviews and step-by-step instructions for mixing or injecting at home.

Within moments of joining one group, a seller posted contact information, where the majority of transactions occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Item Information and Pricing

Inside these communities, messages display dark colored packages with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how long a injector should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious medical dangers”.